title: Development and characterization of Eudragit based mucoadhesive buccal patches of salbutamol sulfate.
abstract: For systemic drug delivery, the buccal region offers an attractive route of drug administration. Salbutamol sulfate is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease. It's oral bioavailability is ∼40% due to extensive first pass metabolism. Salbutamol sulfate patches were prepared using Eudragit L-100, HPMC, PVA and Carbopol 934 in various proportions and combinations using PEG-400/PG as plasticizers. Patches were laminated on one side with a water impermeable backing layer for unidirectional drug release. The thickness of medicated patches were ranged between 0.23 ± 0.008 and 0.59 ± 0.007 mm and mass varied between 65.23 ± 3.3 and 117.92 ± 4.2 mg. Patches showed an increase in mass and swelling index with PEG-400 when compared with PG. The surface-pH of patches ranged between 6 and 7. Formulations E7 (7.5 mL Eudragit L-100, 15 mL HPMC K4M, 7.5 mL PVA and 2 mL PEG-400), E12 (7.5 mL Eudragit L-100, 7.5 mL PVA, 15 mL Carbopol and 2 mL PEG-400), F7 (7.5 mL Eudragit L-100, 15 mL HPMC K4M, 7.5 mL PVA and 2 mL PG), and F12 (7.5 mL Eudragit L-100, 7.5 mL PVA, 15 mL Carbopol and 2 mL PG) showed high folding endurance. Residence time of the tested patches ranged between 101 and 110 min. The maximum in vitro release was found to be 99.93% over a period of 120 min for formulation F12. Data of in vitro release from patches were fitted to different kinetic models such as Higuchi and Korsmeyer-Peppas models to explain the release profile. Formulations E7 and F7 were best fitted to the non-Fickian, where as formulations E12 and F12 showed Fickian/anomalous drug release. Stability studies indicated that there was no change in the chemical and physical characteristics during the test period.
authors: Department of Pharmaceutics, Gautham College of Pharmacy, Sultanpalya, Bangalore 560 032, Karnataka, India.
authors: Prasanth Viswanadhan
authors: PV
authors: Vasantha
authors: Ayarivan
authors: A
authors: Puratchikody
authors: Sam Thomarayil
authors: ST
authors: Mathew
authors: Ashok Kumar
authors: AK
authors: Balaraman
keywords: 32 full factorial design; Buccal drug delivery; Mucoadhesive patches; Salbutamol sulfate
references: Adv Drug Deliv Rev. 2005 Nov 3;57(11):1666-91
references: 16183164
references: Acta Pharm. 2003 Sep;53(3):199-212
references: 14769243
references: J Microencapsul. 2009 Aug;26(5):456-69
references: 19606940
references: J Pharm Sci. 1961 Oct;50:874-5
references: 13907269
references: Ann Pharmacother. 1992 Jan;26(1):81-91
references: 1351410
references: Eur J Clin Pharmacol. 1987;32(6):631-4
references: 3653233
references: Eur J Pharm Biopharm. 2005 Apr;59(3):475-83
references: 15760728
references: Adv Drug Deliv Rev. 2005 Nov 3;57(11):1556-68
references: 16198441
references: Acta Pharm. 2007 Mar;57(1):61-72
references: 19839407
references: Pharm Acta Helv. 1985;60(4):110-1
references: 4011621
references: Drug Discov Today Technol. 2005 Spring;2(1):59-65
references: 24981756
references: J Pharm Sci. 1983 Oct;72(10):1189-91
references: 6644570
references: J Pharm Pharmacol. 1991 Jul;43(7):457-64
references: 1682457
references: Pharmacotherapy. 1984 May-Jun;4(3):105-21
references: 6739311
references: AAPS PharmSciTech. 2007 Dec 14;8(4):E107
references: 18181528